Duncan Mckechnie Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 2 days, 12 hours ago
Duncan Mckechnie has an estimated net worth of at least $10.9 million*, as of July 15, 2026. They own 11,001 shares of VRTX stock. They have sold 11,521 shares of VRTX stock since 2021, for an estimated $5.7 million.
Duncan Mckechnie $VRTX SEC Form 4 Insider Trading
Duncan Mckechnie has filed a total of 5 insider trades in $VRTX since 2021. Their most recent trade was a sale of 1,541 shares, made on Jul 02, 2026. Their largest trade was a sale of 2,633 shares, made on Mar 11, 2026. We estimate that they now own 11,001 shares of $VRTX, worth an estimated $5.2 million.
Insider Trading at $VRTX
There have been a total of 577 insider trades reported at $VRTX since 2021, with 40,000 shares purchased and 1.1 million shares sold. The most active insider traders in $VRTX stock have been David Altshuler, Ourania Tatsis, and Bastiano Sanna. The most recent trade was a sale of 1,500 shares reported by Ourania Tatsis (EVP, Chief Reg. & Quality Off.), made on Jul 02, 2026.
History of Insider Stock Trades by Duncan Mckechnie
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
VRTX
|
Sale | 1,541 | Jul 02, 2026 | July 7, 2026, 4:08 p.m. |
|
VRTX
|
Sale | 2,633 | Mar 11, 2026 | March 13, 2026, 4:11 p.m. |
|
VRTX
|
Sale | 2,437 | Mar 04, 2026 | March 6, 2026, 5:05 p.m. |
|
VRTX
|
Sale | 2,500 | Feb 25, 2026 | Feb. 26, 2026, 10 p.m. |
|
VRTX
|
Sale | 2,410 | Feb 25, 2026 | Feb. 26, 2026, 10 p.m. |
$VRTX Executives and Stock Owners with Insider Trades
-
David Altshuler, EVP, Global Research and CSO
-
Ourania Tatsis, EVP, Chief Reg. & Quality Off.
-
Bastiano Sanna, EVP, Cell & Genetic Therapies
-
Stuart A Arbuckle, EVP, COO
-
Jeffrey M Leiden, Executive Chairman
-
Charles F Jr Wagner, EVP & Chief Financial Officer
-
Carmen Bozic, EVP and CMO
-
Reshma Kewalramani, CEO & President
-
Joy Liu, SVP, General Counsel
-
Kristen Ambrose, SVP & Chief Accounting Officer
-
Amit Sachdev, EVP Chief Patient & Ext Af Off
-
Edward Morrow Iii Atkinson, EVP, Chief Technical Ops. Off.
-
Jonathan Biller, EVP and Chief Legal Officer
-
David Altshuler, EVP, Chief Scientific Officer
-
Joy Liu, EVP and Chief Legal Officer
-
Duncan Mckechnie, EVP, Chief Commercial Officer
-
Mark E. Bunnage, EVP, Chief Scientific Officer
-
Amit Sachdev, EVP, Chief Patient Officer
-
Charles F Jr Wagner, EVP, CO & FO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.